OPS-Code
6-003:
Administration of medication: Administration of medication, list 3
- 6-003.1 Amphotericin B lipid complex, parenteral
- 6-003.3 Carmustine, implant, intrathecal
- 6-003.4 Dibotermin alfa, bone graft
- 6-003.6 Ibritumomab tiuxetan (90Y), parenteral
- 6-003.7 Enzyme replacement therapy in patients with lysosomal storage disorders
- 6-003.8 Botulinum toxin
- 6-003.9 Administration of surfactant in newborns
- 6-003.a Sunitinib, oral
- 6-003.b Sorafenib, oral
- 6-003.c Ranibizumab, intravitreal
- 6-003.d Pegaptanib, intravitreal
- 6-003.e Nelarabine, parenteral
- 6-003.f Natalizumab, parenteral
- 6-003.g Lenalidomide, oral
- 6-003.h Eculizumab, parenteral
- 6-003.j Clofarabine, parenteral
- 6-003.k Anidulafungin, parenteral
- 6-003.n Non-pegylated asparaginase, parenteral
- 6-003.p Pegylated asparaginase, parenteral
- 6-003.q Dexrazoxane, parenteral
- 6-003.r L-asparaginase from Erwinia chrysanthemi [Erwinaze], parenteral
- 6-003.s Abatacept, intravenous
- 6-003.t Abatacept, subcutaneous
Note
Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).